Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Duramed Research
The overall study duration will be approximately 16 weeks. After a screening/baseline period of up to 4 weeks patients will be randomized to receive either placebo tablets or Cenestin 0.3mg tablets
Age
30–80
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Naturally or surgically postmenopausal
At least 12 months since last menses or 6 weeks past surgery
Minimum of 7 daily or 50 weekly moderate to severe hot flashes
You may not be if
Any contraindication to natural or synthetic estrogens
